rs769840061

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_001286105.2(CLN3):​c.-15C>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000477 in 1,612,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000048 ( 0 hom. )

Consequence

CLN3
NM_001286105.2 5_prime_UTR_premature_start_codon_gain

Scores

7
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:9

Conservation

PhyloP100: 5.07

Publications

3 publications found
Variant links:
Genes affected
CLN3 (HGNC:2074): (CLN3 lysosomal/endosomal transmembrane protein, battenin) This gene encodes a protein that is involved in lysosomal function. Mutations in this, as well as other neuronal ceroid-lipofuscinosis (CLN) genes, cause neurodegenerative diseases commonly known as Batten disease or collectively known as neuronal ceroid lipofuscinoses (NCLs). Many alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
CLN3 Gene-Disease associations (from GenCC):
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • neuronal ceroid lipofuscinosis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2196686).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000479 (70/1460748) while in subpopulation MID AF = 0.00504 (29/5752). AF 95% confidence interval is 0.00361. There are 0 homozygotes in GnomAdExome4. There are 31 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001286105.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
NM_001042432.2
MANE Select
c.206C>Tp.Ser69Leu
missense
Exon 4 of 16NP_001035897.1
CLN3
NM_001286105.2
c.-15C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 13NP_001273034.1
CLN3
NM_000086.2
c.206C>Tp.Ser69Leu
missense
Exon 3 of 15NP_000077.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN3
ENST00000636147.2
TSL:1 MANE Select
c.206C>Tp.Ser69Leu
missense
Exon 4 of 16ENSP00000490105.1
CLN3
ENST00000359984.12
TSL:1
c.206C>Tp.Ser69Leu
missense
Exon 3 of 15ENSP00000353073.9
CLN3
ENST00000565316.6
TSL:1
c.206C>Tp.Ser69Leu
missense
Exon 3 of 14ENSP00000456117.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152068
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000561
AC:
14
AN:
249602
AF XY:
0.0000445
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000531
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000479
AC:
70
AN:
1460748
Hom.:
0
Cov.:
31
AF XY:
0.0000427
AC XY:
31
AN XY:
726550
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33468
American (AMR)
AF:
0.000157
AC:
7
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000698
AC:
6
AN:
85964
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.00504
AC:
29
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000225
AC:
25
AN:
1111470
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152186
Hom.:
0
Cov.:
32
AF XY:
0.0000941
AC XY:
7
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41498
American (AMR)
AF:
0.00
AC:
0
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000302
ExAC
AF:
0.0000330
AC:
4
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Neuronal ceroid lipofuscinosis 3 (3)
-
3
-
not provided (3)
-
1
-
Inborn genetic diseases (1)
-
1
-
Neuronal ceroid lipofuscinosis (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.11
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.73
D
Eigen
Benign
-0.041
Eigen_PC
Benign
-0.013
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.97
D
M_CAP
Uncertain
0.088
D
MetaRNN
Benign
0.22
T
MetaSVM
Uncertain
0.37
D
MutationAssessor
Benign
1.9
L
PhyloP100
5.1
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.29
Sift
Benign
0.15
T
Sift4G
Benign
0.40
T
Polyphen
0.58
P
Vest4
0.20
MutPred
0.42
Loss of glycosylation at S69 (P = 0.0217)
MVP
0.93
MPC
0.24
ClinPred
0.14
T
GERP RS
5.5
Varity_R
0.044
gMVP
0.32
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769840061; hg19: chr16-28500627; COSMIC: COSV100343814; COSMIC: COSV100343814; API